Health
4.5
Mark Cuban's Cost Plus Drugs targets rare disease drug manufacturing costs
Published 17 h ago1 sourceEvidence: Reported
SeverityModerateAssessedDeveloping storySTAT NewsLow-rated sourceUS
HealthReportedMedium
5.0
US new drug launch prices dip slightly but remain high; median net price up 35% since 2022
STAT analysis finds median net launch price for 202 new medicines rose 35% to $257,000 in 2025 from $173,000 in 2022, though prices dipped slightly last year. The trend underscores persistent high launch pricing despite policy scrutiny, with implications for payer budgets and patient access.
Score Breakdown
Mosaic Score5.0
Model confidence0.7
Significance0.5
Source credibility0.1
Intelligence Tags
Entities
United Statescountry
Related signals
8 foundHealth
6.2
Roche reviews Germany investments over healthcare cost cuts; Gilead bowel drug advances
Published 2 d ago4 sourcesEvidence: Reported
SeverityModerateAssessedDeveloping storySTAT NewsLow-rated sourceDE · US
Geopolitics
5.8
Greece targets major role in European pharma production, research
Published 2 d ago3 sourcesEvidence: Reported
SeverityModerateCapital.grLow-rated sourceGR
Markets
5.5
GSK to cut 1,217 jobs in Wallonia, pivots to oncology from vaccines
Published 1 d ago1 sourceEvidence: Reported
SeverityModerateLe MondeBE · GB
Health
5.2
AstraZeneca to Present Survival Data from Four Phase 3 Trials at ESMO 2026
Published 2 d ago1 sourceEvidence: Reported
SeverityModerateDagens IndustriLow-rated source
Health
5.2
Brazil caps semestral HIV injection at R$20,914; not in SUS
Published 2 d ago1 sourceEvidence: Reported
SeverityModeratePoder360BR
Health
5.2
Lilly criticizes Belgium's refusal to reimburse obesity drug Mounjaro
Published 16 h ago1 sourceEvidence: Reported
SeverityModerateLe SoirLow-rated sourceBE
Health
5.1
CMS proposes Medicare Part D cost-sharing, PBM transparency rules under CAA 2026
Published 1 d ago1 sourceEvidence: Reported
SeverityModerateFederal RegisterLow-rated sourceUS